Nevertheless, this is the first nationwide large observational study in the literature to examine both the initiation of ET and the corresponding survival outcomes when radiation therapy was omitted after lumpectomy in older women with early‐stage HR+/HER2‐ breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.